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Abstract 
Purpose: To undertake a systematic review  of the high mortality rate of Middle East respiratory 
syndrome coronavirus infections (MERS-CoV) among healthcare personnel in the Middle East. 
Methods: To conduct this systematic review various electronic databases were searched for earlier 
recorded studies. Prisma guidelines were used to shortlist the studies based on the inclusion and 
exclusion criterion. Finally, twelve studies were selected and analysed for the systematic review. 
Results: Twelve articles were selected after filtering 184 articles on Coronavirus. The studies chosen 
for this systematic review which outline the transmission information of MERS-CoV among health care 
personnel. A majority of studies were from Saudi Arabia, as the prevalence of Mers-CoV in Saudi 
Arabia is higher than in other countries in the region. Mers-CoV transmission into humans was mainly 
expected from infected dromedary camels. 
Conclusion: The results indicate that the use of infection control procedures and protocols, which 
include ensuring that all persons with respiratory infection symptoms adhere to respiratory hygiene, 
hand hygiene, and cough etiquette, would minimize the infection rate among HCPs. The required 
consumables for maintaining hand hygiene should be readily available to all HCPs. 
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The Middle East respiratory syndrome (MERS) is 
a recently described virus in humans [1,2]. 
Numerous cases in many countries around the 
world have been reported like Qatar, United Arab 
Emirates, Oman, and Austria, but Saudi Arabia is 
the primary source  [2,3].Coronaviruses generally 
effectuated mild upper respiratory illnesses [1]. 
The occurrence of severe acute respiratory 
syndrome (SARS) and  the Middle East 
respiratory syndrome (MERS) has drawn 










The signs and symptoms in most cases are flu-
like syndromes, but in more severe cases life-
threatening disease occurs, like SARS and 
pneumonia [5,6]. However, coronaviruses 
constitute a significant cause of the Middle East 
respiratory syndrome (MERS) which occurs not 
just in humans but also found in a range of farm 
animals including chicken. MERS is reported to 
be found in camels which serves as a reservoir 
for the virus [7].  
 
Middle East respiratory syndrome coronavirus 
(MERS-CoV) is similar to other viruses which 
spread from infected human secretions, such as 
sneezing, coughing, because its human-to-
human transmission [8]. A close contact with 
infected people who recently travelled from the 
Middle East or nearby area had become a 
significant cause for spreading of coronavirus 
infection [9]. Hospital settings also play a crucial 
role in coronavirus transmission [10,11]. The first 
case of MERS-CoV was initially detected in the 
year 2012-June, presented as a respiratory tract 
infection in Jeddah city in Saudi Arabia who later 
died of renal failure and pneumonia [12]. 
 
From the beginning of 2017 till Jan-2018 101 
cases of MERS-CoV infections in the Middle 
East were reported, out of which 6.93 % of 
recorded cases were among in healthcare 
personnel (HCP’s), and the rest 93.07 % cases 
were of those patients who were not HCP’s but 
had recent healthcare exposure [13]. The current 
understanding of the epidemiology of MERS-CoV 
transmission and infection control procedure is 
based on the experiences with the other viruses. 
[2]. However, the pathway through which the 
virus spreads is not currently well understood. 
 
The objective of this systematic review was first 
to summarize the transmission of MERS-CoV, 
with an aim to identify a problem approach which 
could prevent in spreading of this virus. The 
author suggests the use of recommended 
personal protective equipment and execution of 
infection control procedures can help in 
protecting HCP’s. 
 
The primary objective was to determine the 
human-to-human transmission of MERS-CoV in 
health care personnel. A secondary objective 
was to identify and characterize epidemiological 
and clinical characteristics of persons with 
healthcare-associated infections and to 
understand the factors contributing in spreading 
of MERS-CoV transmission within the healthcare 
settings. In this review, the known risk of 
transmission within health care settings were 
discussed, and relevant recommendations to 





Various electronic databases were searched, 
including PubMed, Science Direct and Google 
Scholar, for earlier reported studies on the 
subject. A systematic review was conducted on 
the shortlisted studies based on the inclusion and 
exclusion criterion of the study following Prisma 
guidelines with consideration on four pre-defined 
themes (clinical characteristics/epidemiology, 
reservoirs/origins, virology and therapeutics 
prevention) for published studies.  
 
Search eligibility criteria 
 
Recent studies done on MERS-CoV in the 
English language which fulfilled the review 
criteria were selected for the systematic review of 




Keywords used were ‘‘coronavirus’’, ‘‘MERS-
CoV’’, in combination with “human studies”, 
‘‘transmission’’, randomized controlled trials 
(RCT), case-control designs, prospective or 
retrospective cohort designs. 
 
This effort resulted in 184 relevant studies 
primarily based on “MERS-CoV in the Middle 
East” and secondly in studies since 2010, of 
these, 12 articles were selected for this study. 
 
Primary search - databases for data 
collection 
 
All types of databases and other journal 
websites, like Google Scholar, PubMed, 
Emerging infectious diseases, BMC Public 
health, The New England Journal of Medicine, 
American Journal of Infection Control, Journal of 
Epidemiology and Global Health, Journal of 
Infection and Public Health, and European 
Society of Clinical Microbiology and Infectious 
Diseases, were used for primary search.  
 
The extracted data from these journals includes 
authors’ name, type of study, publication year, 
number of patients, sample size and level of 
study. The outcomes of interest included 
measures of morbidity and mortality rate. The 
end result recorded in the chosen studies 
included improvement of symptoms, infectious 







Figure 1: Prisma flowchart which summary of the included and excluded studies for the systematic review 
 
Secondary search - databases for data 
collection 
 
After the primary search was concluded on the 
cited references in the articles, primary screening 
of the articles was mainly concentrated on the 
scanning of the title and the abstract.  Articles 
which passed the primary screening were read in 
full detail for the final inclusion of articles (Figure 
1). 
 
Studies with full-text were only included in the 
review and not just abstract. Studies which 
discussed the vaccine therapy of MERS-CoV 
were excluded. Studies on MERS-CoV in 
different countries other than the Middle East 
were also excluded. Similarly, articles based only 
on MERS-CoV in children, in non-health care 
personnel and studies in animals were also 
filtered out. After filtering these categories, only 
twelve studies are left. The method used here is 
a qualitative systemic review. 
 
A wide range of environmental, medical and 
scientific databases was searched to extract 
relevant citations and to identify primary studies 
on MERS-CoV in health care facilities. 
 
Assessment of study quality 
 
Clinical studies included in this review were 
critically appraised by evaluating the study 
design, transmission allocation, possibility of bias 
in the selection of the control group and 
consistency in reporting the study outcomes. 
 
Included studies in this review are tabulated 
narratively and were grouped by a systematic 
strategy. Details of the included study were 
presented including year of publication, author’s 
name, type of study, number of patients, number 
of males, number of females, level of study, and 
the studies are arranged according to the 




A total of twelve articles were selected after 
filtering 184 articles on Coronavirus. The studies 
chosen for this systematic review are 
summarized in Table 1. Table 2 outlines the 
transmission information of these studies in 
healthcare personnel.  
 
A total of ten articles were from Saudi Arabia 
from different cities mostly from Jeddah, one 
from United Arab Emirates (Abu Dhabi) and one 
from Arabian Peninsula. Majority of studies were 
from Saudi Arabia, as the prevalence of Mers-
CoV in Saudi Arabia is high compared to other 
countries. Mers-CoV transmission into humans 
was mainly expected from infected dromedary 
camels [1]. Out of 12 selected studies, 3 were 




Table 1: Summary of all studies on transmission of MERS-CoV Infection among HCP’s in Middle-East 
 
Study Type of study Number of 
participants 
Male Female Level of 
study 










Hall et al [2] Case report 48 27 29 Low  


















Oboho et al [5] Retrospective 78 NR NR Low  
Khalid et al [6]* A cross-sectional (Observational study) 117 28 89 Low  
Shalhoub et al [7] Primary case 1 0 1 Low  
Maltezou et al [8] Review study 155 NR NR Moderate  
Sherbini et al [9] Retrospective 5 NR NR Low  
 
Memish et al [10] 




























NR=not reported *Questionnaire 
 
signs and symptoms of Mers-CoV infections are 
standard in all the twelve articles. A single study 
mentioned the history of a patient of travelling 
from Amman, Jordan before getting infected; so 
it illustrates the pathway of transmission from 
camel to human then to HCP [3].  
 
Another study reported a healthy outcome after 
HCP contact with the pathogen resulted in a 
negative test for MERS-CoV infections. Three 
studies have shown smoking as a risk factor, 
however it is unclear that diabetes, asthma or 
obesity has any association with acquiring 
MERS-CoV infection among HCP. Most of the 
studies have a total duration of exposure of 
pathogen between less than an hour to 4 h with 
the exception of one study. Symptoms are 
reported to appear after 14 days for first 
exposure to the pathogen. However, changing 
linen, feeding, bathing, lifting, giving medicines, 
placing IV or other catheters are the major tasks 
performed by HCP’s causing transmission of the 
MERS-CoV infection. Studies reported that 
personal protective equipment used by HCP’s 
were masks and gloves. Table 1 included the 
name of the first author, type of study (case 
report, primary case, observational study, 
retrospective study, prospective descriptive study 
and review study), number of patients and the 
level of each study. Missing information from any 
studies is marked as “NR”, meaning not reported. 
 
Table 2-4 summarises the data on risk factors, 
exposure history, touched patient (direct or 
indirect), type of exposures to the patient (the 
activity that leads to the transfer of pathogen), 
presence during high-risk procedure, use of 
personal protective equipment. In the end, the 
outcome of HCP’s as healthy or diseased was 
presented. Nahid et al included five HCP’s, three 
of them were staff nurses, and the other two 




Globally it has been a lot of concern about the 
transmission of the MERS-CoV [14]. Due to a 
high mortality rate of MERS-CoV, this systematic 
review was conducted to summarize the 
available studies in the scope of transmission of 
coronavirus in health-care personnel for 
prevention of coronavirus infection based on 
previous reports [15]. 
 
The noticeable growth in the number of patients 
infected with MERS-CoV in the Middle East 
could be illustrated by secondary human-to-
human transmission, rather than by an 
unexpected increase of primary cases in the 
community [16]. 
 
Studies discussed the risk factors like diabetic 
mellitus, smoking, and asthma (13). After filtering 
out major risk factors of HCP’s by excluding 
those with a history of exposure to dromedary 
camels, proximity of health care personnel to 
patients, handling of human biological fluids, 
such as respiratory secretions, urine, sputum, 
feces, or blood found to increase the possibility 
of transmission of MERS-CoV infections among 
HCP’s [17. 
 
Three articles discuss diabetes mellitus as a risk 
factor and other three about smoking [18. 




Table 2: Transmission information summary of studies on transmission of Middle East Respiratory Syndrome Coronavirus Infection among HCP’s in the Middle East  
  











generating) (aerosol  
Use of personal 















Give meds =4 
Place IV or other 
catheters =5 
=5 Intubation  
=4 suctioning Airway  
=2 induction Sputum  
Regular mask =5 
-Respirator 
(n95 or equivalent) =3 



















bedding, equipment, or 




Emptied bedpan =11 
Came within 1 m of 
patient =43 
Airway suction =24 
Nebulizer treatment = 
14 
Sputum induction = 
11 





eye protection =0 
N95 mask =16 
hand hygiene =48 
Healthy 














<10 min =1 
10–30 min =6 
>30 min =2 
Unknown =5 
14 










cannula or oxygen 
mask (n = 3), 
administration of 
inhaler or nebulizer 
treatment (n = 2), 
intubation (n = 1), 
suctioning before 
intubation (n = 1); 
healthcare workers 
could perform >1 of 







Gown gloves, and surgical 













Table 3: Transmission information summary of studies on transmission of Middle East Respiratory Syndrome Coronavirus Infection among HCP’s in the Middle East 
 












Use of personal 
protective equipment Outcome 
Khan et al 
(4) NR NR NR NR NR NR Healthy 
Oboho et al 
(5) NR 




cause during the 
14 days before 
the onset of 
illness is admitted 
to the hospital 
NA NA NA NA Diseased  
Khalid et al. 
(6) NR NR NR NR NR NR Healthy 
Shalhoub et 
al. (7) smoker 2day NR 
Performed standard 
nursing care that 
included taking vital 
signs, intravenous 
access, accompanying 
the patient to the 
radiology department, 
inserting peripheral and 
inserting a urinary 
catheter 
NR NR easedDis  
Maltezou et 





2 of them in 
the hemodialysis unit NR 
13 of them don't use 
personal protective 
equipment apart from 
gloves 
 Diseased
 of one and













Table 4: Transmission information summary of studies on transmission of Middle East Respiratory Syndrome Coronavirus Infection among HCP’s in the Middle East 
 












Use of personal 
protective equipment Outcome 
Sherbini et 
al. (9) NR NR 
close 




NR NR NR NR NR NR Diseased  
Rabaan et 

















Lifting positioning =14 
Emptying bedpan =8 
Changing linen =11 













The highest attack 
rate (29.4 %) is among 
radiology technicians, 
followed by respiratory 
therapists (3.2 %), 





Direct contact =1 
Aerosol-generating 
procedure =3 
Nose and mouth covering 
with N95 respirator or 
medical mask 


















acquiring this infection and one study suggested 
categorizing HCP with diabetes mellitus as a 
high-risk group [19. One study indicates that the 
current threat of transmission within health car 
facilities remains small and that the 
recommended infection control measures are 
adequate. 
 
Majority of studies mentioned the exposure time 
to infect HCP’s by less than one hour, an 
exception to 2 studies which reported higher 
exposure time or multiple exposure occasions. 
Transmission of the pathogen from human-
human doesn’t take much time and is through 
droplet transmission, as it is reported that 
performing an activity related to a respiratory 
system like the aerosol generation is highly likely 
infect a HCP [20]. In another single study, due to 
lack of appropriate following the infection control 
measures, some HCP’s had to face maximal 
exposure [21]. Not a single article stated remain 
animal-human transmission except one, but it’s 
not clearly identified.  
 
Most of the studies here confirm that direct 
contact of the equipment related to the infected 
person by HCP results in strong association with 
transmission of MERS-CoV Infections [22]. 
Nurses have high chances of getting infected 
when compared to others as they are mostly 
involved in activities such as hemolysis and 
drawing blood. Several studies pointed towards 
the possible cross-contamination through 
contaminated surfaces and medical devices in 
use by HCP [21].
 
In fact, most of the studies showed the need for 
the use of various personal protective equipment 
like gloves and mask and suggested this may 
lead to protect the people from the viruses [2]. 
One study mentioned that the use of N95 mask 
is less compared to the regular mask because 
it’s more expensive, but the protection is 
adequately even with regular mask. 
 
The questionnaire studies state that the safety of 
HCP is its primary concern. In the survey Khan 
MU et al [4], it showed that majority of HCP were 
well aware of the precautionary measures and 
hygienic issues to get prevented from 
transmission of pathogens. However, Ali et al. 
focused on the hospital infrastructure and its 
design which is also a significant factor for 
spreading the infection [11].  
 
Finally, this study concludes infection prevention 
program and good practices to be followed by 
the management of hospitals to minimize the 
spread of MERS-CoV infections and protect staff, 




Health care personnel (HCPs) are at high risk of 
transfer of MERS-CoV from infected patients 
through the secondary human-to-human 
transmission. The HCPs in most of the studies 
showed good attitude and knowledge of MERS. 
The infection prevention program and proper 
procedures that were used might contribute in 
demonstrating lack of transmission. Nonetheless, 
rapid identification of high-risk patients with 
MERS-CoV and implementation of infection 
control precautions can help protect HCPs. 
Provision of supporting healthcare facilities to 
prevent the transmission and to improve the 
safety and protection of HCPs remain a priority. 
However, face masks, gloves and gowns should 
be used during all procedures, especially aerosol 
generation procedure. In general, infection 
control procedures should be strictly adhered to, 
and HCPs with chronic disease conditions such 
as diabetes and asthma ideally should be kept 
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